Clinical trial NCT06295874: The Effect of Aromatherapy Massage on Pain, Anxiety and Comfort
Official title: Effect of Aromatherapy Massage Applıed to Intensıve Care Patıents on Physıologıcal Parameters, Paın, Anxıety and Intensıve Care Comfort
Study type: INTERVENTIONAL
Overall status: RECRUITING
Phase: NA
Conditions: Respiratory Insufficiency
Pulmonary Disease, Chronic Obstructive
Diabetes Mellitus, Type 2
High Blood Pressure
Stroke, Ischemic
Keywords: intensive care
pain
anxiety
comfort
aromatherapy massage
Lead sponsor: Nigde Omer Halisdemir University
Sponsor class: OTHER
First posted: 2024-03-06
Enrollment: 61
Sex: ALL
Minimum age (years): 18
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: yes
Allocation: RANDOMIZED
Intervention model: PARALLEL
Intervention model description: randomized controlled single blind study
Primary purpose: SUPPORTIVE_CARE

Brief summary: Patients in the intensive care unit (ICU) experience physical and psychological discomfort, including pain. Anxiety is a condition frequently encountered in the ICU. The hospital environment, especially the ICU, is reported as a significant cause of anxiety for patients. Comfort is a holistic, subjective and multidimensional concept that is affected by physical, environmental, social and psycho-spiritual contexts and changes over time and space. Comfort in intensive care is often associated with pain relief and end-of-life care. Assessment tools have been developed to measure patient comfort in the ICU, including levels of pain, delirium, and sedation. This work; Patients who are monitored in intensive care under high-flow and oxygen are treated with a mixture of lavender, thyme and eucalyptus oil (20 ml; lavender oil 5 drops, thyme oil 4 drops, eucalyptus oil 3 drops and 20 ml almond oil) twice a day for three days. This study was conducted to determine the effect of aromatherapy massage applied for a total of 30 minutes on some physiological parameters, pain, anxiety and intensive care comfort of the patients.


Eligibility criteria: Inclusion Criteria:

* 18 years of age and over,
* Conscious patients,
* Staying in intensive care for 24 hours or more,
* Those with stable hemodynamic status,
* Receiving O2 therapy,
* Intubated patients, patients who have passed 24 hours after being extubated,
* Those whose saturation level is 85 and above

Exclusion Criteria:

* Patients with peripheral neuropathy or quadriplegia,
* Patients with open wounds on their body,
* Patients receiving analgesia and sedation infusion,
* Patients who are sedated,
* Patients in delirium,
* Patients with an allergy detected before starting the application,
* Patients with a GKS (Glasgow Coma Scale) score of 3 and below

Primary outcomes:
measure: Patient Introduction Form
timeFrame: 2 years
Secondary outcomes:
measure: Patient Follow-up Form
timeFrame: 2 years
Other outcomes:
measure: Drug Monitoring Form
timeFrame: 2 years
measure: Visual Pain Scale
timeFrame: 2 years
measure: Face Anxiety Scale
timeFrame: 2 years
measure: Comfort Rating Scale
timeFrame: 2 years
Locations:
city: Nigde
country: Turkey
facility: Ömer Halisdemir University Training and Research Hospital
Study officials:
References: